Navigation Links
Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace
Date:3/18/2009

Establishing Wholly-owned Subsidiary to Enable BBK Worldwide to Better Serve Asia-Pacific Clinical Trial Enrollment Concerns

NEWTON, Mass., March 18 /PRNewswire/ -- BBK Worldwide, a global leader in patient recruitment for clinical trials, has announced the opening of BBK Worldwide -- Osaka, G.K., in Osaka, Japan. The company will be committed to supporting Japanese pharmaceutical, biotechnology, and medical device companies, as well as CROs and SMOs, to help these groups more rapidly and effectively enroll and retain patients as participants in clinical research studies.

Throughout the world, the single most costly delay in bringing new treatments to market is the slow enrollment of clinical trials, with each day a trial doesn't enroll potentially equivalent to millions of dollars in lost revenue due to treatment patent limitations. Moreover, it takes an average of 2.5 years longer for a drug to become available in Japan than in the U.S. or Europe, according to Japan's Pharmaceuticals and Medical Devices Agency (PMDA).

Understanding the primary causes for this specific delay was the first step for BBK in exploring the Japanese marketplace, according to company co-founder and president Bonnie Brescia. "We conducted in-depth interviews with medical directors and leaders of clinical trial teams at many of the major Japanese pharmaceutical companies," said Brescia, "And we found that four of the five top reasons for delay were issues that we have solved for our clients' studies in more than 30 countries throughout the world. Inefficient patient accrual, contracting with sites, attitudes of patients or referring physicians, and insufficient or inaccurate enrollment feasibility planning -- when we heard these concerns, we knew that we could offer real value to the Japanese marketplace."

"While we believe we can offer expert consultation and services immediately for study sponsors with recruitmen
'/>"/>

SOURCE BBK Worldwide
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
2. Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
3. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
4. Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
5. Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
6. Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company
7. Oregon Health & Science University Knight Cancer Institute Enhances Patient Care With Monaco(R) Radiation Treatment Planning System
8. Mayo Clinic CEO Offers New Vision for Personalized Patient Care
9. Photos: Project Runways Tim Gunn Launches Addressing Psoriasis(TM) Campaign to Advocate That Patients Shouldnt Let Psoriasis Impact Personal Style
10. NPSF Issues New Universal Patient Compact During Patient Safety Awareness Week
11. Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... England , May 22, 2013 ... novel drug-only formulation of glycopyrronium bromide designed using Prosonix, ... pharmaceutical company developing a portfolio of inhaled Respiratory ... clinical study with PSX1002 that will assess its effect ... of doses in patients with moderate to severe chronic ...
(Date:5/21/2013)... , May 21, 2013  On May ... FCN ), the global business advisory firm dedicated ... value (the "Company"), announced that it has combined ... were formerly included within the Corporate Finance/Restructuring segment ... segment to form a single integrated practice whose ...
(Date:5/21/2013)... 21, 2013  The Lindsley F. Kimball Research Institute of ... a Grand Challenges Explorations winner, an initiative funded ... Sara Lustigman , Head of the Laboratory ... development research project, titled Innovative 3-D in vitro ... needed to screen drugs to help eliminate onchocerciasis (river blindness) ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 ... tracking to reporting eLearning solution using Tin Can ... and dashboard tool. CLD is a leading developer ... and medical device companies worldwide. , Tin ... standard that helps learners and trainers more accurately ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3
... U.S. HIV/AIDS Patients Live in States Now Providing ... Medicaid Coverage ... ,Monogram Biosciences, Inc. (Nasdaq: MGRM ) today announced that ... a diagnostic used to determine patient candidacy for Pfizer,s new,HIV ...
... or drop of liquid and the shape of the surface ... formula published this week in Physical Review Letters. , ... for a number of areas, including the chemical industry and ... explain how the relationship between the liquid and the surface ...
... in Europe ... expertise., BOSTON, April 7, 2008 The company is ... based in the United,Kingdom. Penny will work closely with US ... European and global,business. Penny specializes in the provision of actionable ...
Cached Biology Technology:New York Medicaid Program Establishes Coverage for Trofile(TM) 2New York Medicaid Program Establishes Coverage for Trofile(TM) 3New York Medicaid Program Establishes Coverage for Trofile(TM) 4Physicists saved from drowning in complexities of wetting theory 2Observant LLC Appoints Two New Directors to the Senior Management Team 2
(Date:5/21/2013)... long time that some creatures evolve more quickly than ... But it may be that height plays a role, ... U. S. National Evolutionary Synthesis Center. , In ... journal Nature Communications , Lanfear and colleagues report ... a database of global patterns in plant height for ...
(Date:5/21/2013)... whale entangled in fishing gear, scientists showed for the ... and swimming behavior. The monitoring revealed how fishing gear ... energy as they drag gear for months or years, ... scientists in this entanglement response suction-cupped a cellphone-size device ... right whale called Eg 3911. The Dtag, developed at ...
(Date:5/21/2013)... concept of "place" is increasingly being considered in ... have a new resource that can help them ... with the places in their lives. , ... new book co-edited by the Pacific Northwest Research ... human-centered approach to conservation. The book is published ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3
... VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) ... patents for the development and commercialization of stem cell-based ... South San Francisco, is one of the world,s leading ... technology to transform the ways drugs are discovered and ...
... straightforward experiment, researchers have provided some clues to one ... came together to form the basis of life. ... JBC , demonstrated how ancient RNA joined together ... single-stranded precursor to DNA, normally expands one nucleic base ...
... Dec 18, 2008 Those ferocious Hollywood meat-eating dinosaurs ... had a much softer side: the males might even ... far-flung study conducted by a Texas A&M University researcher. ... Geology and Geophysics, and team members from Montana State ...
Cached Biology News:VistaGen, WARF sign license agreement for human embryonic stem cell technology 2Male dinosaurs may have been prehistoric babysitters, study shows 2
Homo sapiens postsynaptic protein CRIPT Antigen: Recombinant Protein...
... The high-performance triple quadrupole 1200L ... in today's cost-conscious environment - incorporating ... solutions for all liquid chromatography analytical ... (API) interface and the Transmission Quadrupole ...
Human Legumain Affinity Purified Polyclonal Ab...
Mouse Endoglin/CD105 Fluorescein MAb (Clone 209701)...
Biology Products: